BEAM (Biotech companies in Europe combating AntiMicrobial Resistance) represents European small and medium-sized biotech companies involved in developing innovative products to tackle antimicrobial resistance, including preventative and curating therapies, and diagnostic tests. BEAM gives its members a unique voice to propose and support policies and incentives in antimicrobial research and development in Europe. BEAM recommends bold incentives that warrant action by policymakers to stimulate much needed innovation.
| Website | https://beam-alliance.eu/ |
| Revenue | $3 million |
| Employees | 10 (1 on RocketReach) |
| Address | 29 Avenue Tony Garnier, Lyon, Auvergne-Rhône-Alpes 69007, FR |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Keywords | Antimicrobial Resistance, Biotechnology, Biotech, Drug Development, Antibiotics, Pharmaceutical, Infection Control, Research And Development, Small And Medium Enterprises, Therapeutics, Health Technology, Innovation, Medicine, Microbiology, Prevention, Cure, Public Health |
| Competitors | EMEC: European Marine Energy Centre, Sustainable Energy Authority of Ireland (SEAI), SolarPower Europe, International Hydropower Association (IHA), WindEurope, EU Careers by EPSO, Clean Energy Council, European Environmental Bureau, Climate Group, Sustainable Energy Coalition +34 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular BEAM Alliance employee's phone or email?
The BEAM Alliance annual revenue was $3 million in 2026.
Frederic Peyrane is the Managing Director of BEAM Alliance.
1 people are employed at BEAM Alliance.
BEAM Alliance is based in Lyon, Auvergne-Rhône-Alpes.
The NAICS codes for BEAM Alliance are [325, 32].
The SIC codes for BEAM Alliance are [283, 28].